A Race Against Time: The Urgent Need for Funding Rare Disease Treatments
Six months ago, Emily Forrester’s life was irrevocably altered by a diagnosis no parent expects. Her daughter, Leni, was found to have Sanfilippo syndrome, a rare genetic disorder leading to childhood dementia. Despite showing no initial symptoms, a relative’s genetic test revealed the potential for the condition, prompting further investigation that confirmed the devastating truth just before Leni’s second birthday.
Understanding Sanfilippo Syndrome: A Cruel and Rapidly Progressing Disease
Sanfilippo syndrome is caused by an enzyme deficiency, preventing the body from breaking down essential molecules. This leads to catastrophic brain damage, resulting in the loss of memory, speech, mobility, and premature death. Currently, there is no cure or approved treatment available in the UK.
“If she has to wait six months, that could signify she can no longer talk. If she waits 12 months, that could mean she loses the ability to walk,” Ms. Forrester explained, highlighting the critical timeframe for intervention.
The Promise of Treatment and the Barriers to Access
Hope exists in the form of a clinical trial expected to start in the United States. This treatment aims to replace the missing enzyme by implanting a permanent port in the brain, allowing for weekly enzyme infusions. However, access to this potentially life-saving treatment is blocked by a significant hurdle: funding. The cost to fund the US clinical trial is estimated at £5.5m.
A previous clinical trial, run by Great Ormond Street Hospital in London for six years, showed promising results. However, it was halted due to a lack of funding, leading to a decline in the health of children who had previously been thriving with the treatment.
Another potential treatment is being developed by UK-based Professor Brian Bigger, but his research also requires substantial funding to reach clinical trials.
The Fight for Newborn Screening and Increased Funding
Ms. Forrester is advocating for expanded newborn screening programs to detect rare genetic conditions earlier, enabling quicker diagnosis and intervention. She also calls for increased government funding to accelerate the development of game-changing treatments.
She points to the advocacy efforts of singer Jesy Nelson, who successfully raised awareness for spinal muscular atrophy (SMA) by meeting with the health secretary, Wes Streeting. However, Ms. Forrester notes that families without celebrity connections often struggle to gain the attention of policymakers.
“Politicians should prioritize meeting families suffering with the genetic disorders, not only celebrities to get their screen time,” she stated.
A System Failing Rare Disease Patients
Bob Stevens, CEO of the MPS Society, a charity supporting those with mucopolysaccharide diseases (including Sanfilippo), highlighted the disparity in screening practices compared to other countries. He emphasized that early diagnosis is crucial for maximizing the effectiveness of new therapies.
“The UK currently screens for far fewer conditions than many comparable countries, meaning families are often diagnosed only after crucial time has been lost,” Stevens said.
A Department of Health and Social Care spokesperson acknowledged the need for faster diagnosis and improved access to care for rare disease patients, stating they are “working hard to identify new ways to slow down the progress of the dementia, speed up diagnosis and improve our understanding of the disease.”
How You Can Facilitate
Leni’s parents have launched a GoFundMe page to raise funds for Leni’s treatment and to increase awareness of Sanfilippo syndrome.
Frequently Asked Questions
What is Sanfilippo syndrome?
Sanfilippo syndrome is a rare genetic disorder that causes a buildup of harmful substances in the brain, leading to progressive neurological damage.
Is there a cure for Sanfilippo syndrome?
Currently, there is no cure for Sanfilippo syndrome, but research is ongoing to develop effective treatments.
How is Sanfilippo syndrome diagnosed?
Sanfilippo syndrome is diagnosed through genetic testing.
What are the symptoms of Sanfilippo syndrome?
Symptoms include developmental delays, loss of speech, loss of mobility, and cognitive decline.
Where can I learn more about Sanfilippo syndrome?
You can find more information at the MPS Society website.
Keep reading